PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 126 filers reported holding PUMA BIOTECHNOLOGY INC in Q1 2020. The put-call ratio across all filers is 1.24 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $192,996 | -4.4% | 62,458 | +30.8% | 0.00% | 0.0% |
| Q4 2022 | $201,978 | +320.8% | 47,749 | +136.6% | 0.00% | – |
| Q3 2022 | $48,000 | -12.7% | 20,181 | +5.3% | 0.00% | – |
| Q2 2022 | $55,000 | -76.4% | 19,166 | -76.3% | 0.00% | -100.0% |
| Q1 2022 | $233,000 | +37.1% | 80,801 | +44.5% | 0.00% | 0.0% |
| Q4 2021 | $170,000 | +9.0% | 55,901 | +151.8% | 0.00% | 0.0% |
| Q3 2021 | $156,000 | -54.7% | 22,200 | -35.0% | 0.00% | 0.0% |
| Q3 2020 | $344,000 | -18.3% | 34,134 | -15.4% | 0.00% | -50.0% |
| Q2 2020 | $421,000 | +46.2% | 40,334 | +18.2% | 0.00% | 0.0% |
| Q1 2020 | $288,000 | -34.8% | 34,134 | -32.5% | 0.00% | +100.0% |
| Q4 2019 | $442,000 | +22.8% | 50,567 | +543.3% | 0.00% | 0.0% |
| Q3 2018 | $360,000 | – | 7,860 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 1,417,000 | $18,010,000 | 2.24% |
| Palo Alto Investors LP | 1,405,680 | $17,866,000 | 0.87% |
| PFM Health Sciences, LP | 2,838,376 | $36,076,000 | 0.68% |
| TANG CAPITAL MANAGEMENT LLC | 349,400 | $4,441,000 | 0.60% |
| Capital Impact Advisors, LLC | 127,029 | $1,615,000 | 0.59% |
| Leap Investments LP | 29,100 | $370,000 | 0.50% |
| Spark Investment Management LLC | 454,300 | $5,774,000 | 0.40% |
| Partner Investment Management, L.P. | 27,567 | $350,000 | 0.37% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 262,945 | $3,342,000 | 0.26% |
| Rock Springs Capital Management LP | 534,400 | $6,792,000 | 0.25% |